Your browser doesn't support javascript.
loading
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
Howard, James F; Bril, Vera; Vu, Tuan; Karam, Chafic; Peric, Stojan; Margania, Temur; Murai, Hiroyuki; Bilinska, Malgorzata; Shakarishvili, Roman; Smilowski, Marek; Guglietta, Antonio; Ulrichts, Peter; Vangeneugden, Tony; Utsugisawa, Kimiaki; Verschuuren, Jan; Mantegazza, Renato.
Afiliación
  • Howard JF; Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: howardj@neurology.unc.edu.
  • Bril V; Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Vu T; Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
  • Karam C; Penn Neuroscience Center-Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Peric S; Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Margania T; Department of Neurology and Neurorehabilitation, New Hospitals, Tbilisi, Georgia.
  • Murai H; Department of Neurology, School of Medicine, International University of Health and Welfare, Narita, Japan.
  • Bilinska M; Department and Clinic of Neurology, Wroclaw Medical University, Wroclaw, Poland.
  • Shakarishvili R; Sarajishvili Institute of Neurology and Neurosurgery, Tbilisi, Georgia.
  • Smilowski M; Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland.
  • Guglietta A; argenx, Ghent, Belgium.
  • Ulrichts P; argenx, Ghent, Belgium.
  • Vangeneugden T; argenx, Ghent, Belgium.
  • Utsugisawa K; Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan.
  • Verschuuren J; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands.
  • Mantegazza R; Department of Neuroimmunology and Neuromuscular Diseases, Fondazione Istituto Neurologico Carlo Besta, Milan, Italy.
Lancet Neurol ; 20(7): 526-536, 2021 07.
Article en En | MEDLINE | ID: mdl-34146511
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fragmentos Fc de Inmunoglobulinas / Anticuerpos Monoclonales Humanizados / Anticuerpos Monoclonales / Miastenia Gravis Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fragmentos Fc de Inmunoglobulinas / Anticuerpos Monoclonales Humanizados / Anticuerpos Monoclonales / Miastenia Gravis Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article